A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Local Institution - 0047, Petah Tikva

Local Institution - 0001, Vienna

Local Institution, CABA

Local Institution - 0030, Parkville

Local Institution - 0016, Mexico City

Childrens Hospital Of Philadelphia, Philadelphia

Local Institution - 0027, Milan

Local Institution - 0004, Hamburg

Local Institution, Madrid

Local Institution - 0048, Madrid

Local Institution - 0012, Charleston

Childrens Healthcare Of Atlanta, Atlanta

Local Institution - 0044, León

Local Institution - 0028, Bologna

Local Institution - 0006, Cincinnati

Local Institution - 0008, Indianapolis

Local Institution - 0013, Ann Arbor

Local Institution - 0046, Tel Litwinsky

Childrens Mercy Hospital, Kansas City

Local Institution - 0002, Freiburg im Breisgau

Children'S Hospital Colorado, Aurora

Local Institution - 0003, München

Primary Children's Hospital, Salt Lake City

Phoenix Children'S Hospital, Phoenix

Local Institution - 0055, Seattle

Local Institution, Kazan'

Local Institution - 0062, Yekaterinburg

Local Institution - 0057, Novosibirsk

Local Institution, Kemerovo

University Of California San Diego, La Jolla

Local Institution - 0009, Boston

Local Institution - 0011, Houston

Local Institution - 0022, Curitiba

Instituto De Cardiologia Do Rio Grande Do Sul, Porto Alegre

Local Institution - 0020, Campinas

Instituto de Pesquisa PENSI, São Paulo

Universidade Federal De Sao Paulo, São Paulo

Local Institution - 0015, Toronto

Local Institution - 0031, HUS

Local Institution - 0026, Rome

Local Institution - 0018, Mexico City

Local Institution - 0019, Mexico City

Local Institution - 0049, Barcelona

Local Institution - 0040, Leicester

Local Institution - 0042, Bristol

Local Institution, Manchester